Evaluation Of The Impact Of A Call Center In Management Of Metastatic And/Or Advanced Renal Cell Carcinoma Patients Treated With Sunitinib (Sutent) In First Line

CompletedOBSERVATIONAL
Enrollment

70

Participants

Timeline

Start Date

October 7, 2015

Primary Completion Date

July 25, 2018

Study Completion Date

July 25, 2018

Conditions
Metastatic/Advanced Renal Cell Carcinoma
Interventions
OTHER

Best supportive care

BSC may include medications and supportive measures deemed necessary to palliate disease related symptoms and improve quality of life

OTHER

call center

Nurses from a call center will call the patients at regular time to help patients in the management of their cancer, with some dietetic advices, medical advices etc.

Trial Locations (13)

13335

CHU de la Timone, Marseille

29107

CHI de Cornouailles - Oncologie hospitalisation, Quimper

34295

CRLC Val d'Aurelle, Montpellier

54000

Polyclinique Gentilly, Nancy

54100

Polyclinique de Gentilly Service Oncologie Médicale, Nancy

54511

Centre Alexis Vautrin, Vandœuvre-lès-Nancy

57000

Clinique Claude Bernard Chimiotherapie Ambulatoire, Metz

59042

Hopital prive La Louviere, Lille

59300

Hopital Jean BERNARD - Tours - 7eme etage, Valenciennes

66330

Centre Catalan Urologie Andrologie, Cabestany

67091

CHU Strasbourg, Strasbourg

73000

Centre hospitalier de Chambery, Chambéry

74011

Centre Hospitalier d'Annecy, Annecy

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT02187042 - Evaluation Of The Impact Of A Call Center In Management Of Metastatic And/Or Advanced Renal Cell Carcinoma Patients Treated With Sunitinib (Sutent) In First Line | Biotech Hunter | Biotech Hunter